Intensity Therapeutics, Inc. Common stock (INTS) — Defensive Interval Ratio
Intensity Therapeutics, Inc. Common stock (INTS) has a Defensive Interval Ratio of 0 days as of December 2024. Defensive assets of $0.00 (cash $-, short-term investments $0.00, receivables $-) cover 0 days of daily cash needs of $4.81K/day. Check INTS goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Intensity Therapeutics, Inc. Common stock Defensive Interval Ratio (2019–2024)
This chart shows how Intensity Therapeutics, Inc. Common stock's Defensive Interval Ratio has evolved across 6 annual periods from 2019 to 2024. As of December 2024, the ratio stands at 0 days, meaning defensive assets of $0.00 can fund 0 days of operations without new revenue. Also explore Intensity Therapeutics, Inc. Common stoc (INTS) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Intensity Therapeutics, Inc. Common stock (2019–2024)
The table below presents the year-by-year Defensive Interval Ratio for Intensity Therapeutics, Inc. Common stock from 2019 to 2024, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market value of Intensity Therapeutics, Inc. Common stoc.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 0 days | $0.00 | $4.81K/day | $- | $0.00 | ▼ -573 days |
| 2023 | 573 days | $6.22 Million | $10.85K/day | $- | $6.22 Million | ▲ +570 days |
| 2022 | 3 days | $62.30K | $18.68K/day | $- | $0.00 | ▼ -2 days |
| 2021 | 5 days | $51.26K | $10.19K/day | $- | $- | ▼ -8 days |
| 2020 | 13 days | $48.52K | $3.69K/day | $- | $0.00 | ▼ -1475 days |
| 2019 | 1488 days | $4.60 Million | $3.09K/day | $- | $4.56 Million | — |